X0201 4 2004-02-17 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218810 KANNER DOV C/O BIO-TECHNOLOGY GENERAL (ISRAEL) LTD. KIRYAT WEIZMANN REHOVOT, ISRAEL 76326 ISRAEL 0 1 0 0 Executive Vice President Options to purchase Common Stock, $.01 par value per share 4.31 2004-02-17 4 A 0 85000 4.31 A 2014-02-17 Common Stock, $.01 par value per share 85000 564005 D These options will become exercisable as to 21250 shares on each of 2/17/05, 2/17/06, 2/17/07 and 2/17/08, provided that Mr. Kanner is employed by the Company on these dates. /s/ Beata Smith as attorney-in-fact for Dov Kanner 2004-02-19